Signal
Proteogenomic analyses identify novel protein targets and risk models for lung cancer, heart failure, and rheumatoid arthritis-associated
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-06-22 20:58 UTCUpdated 2026-06-22 22:18 UTC
rss
clinical_trialsdrug_developmentgenomicsr_and_dsafety_signals
Trend in the last 24h
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (1 domains)domains are deduped. counts indicate coverage, not truth.1 top source shown
limited source diversity in top sources
Overview
Recent integrative studies combining proteomics and genomics have identified multiple proteins linked to lung cancer susceptibility, heart failure risk independent of BMI, and rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Score total
0.96
Momentum 24h
3
Posts
3
Origins
1
Source types
1
Duplicate ratio
0%
Why now
- Large-scale proteomic and genomic datasets enable integrative analyses for complex diseases.
- Emerging machine learning approaches improve risk prediction and biomarker discovery.
- Addressing unmet needs in lung cancer, heart failure, and RA-ILD could improve patient outcomes.
Why it matters
- Identifies novel protein targets for lung cancer and heart failure, aiding drug development.
- Provides predictive biomarkers and models for early detection of RA-associated lung disease.
- Separates genetic risk factors to refine therapeutic target prioritization beyond confounding traits like BMI.
LLM analysis
Topic mix: lowPromo risk: lowSource quality: medium
Recurring claims
- Integration of lung tissue proteomics and genome-wide association data identifies lung cancer susceptibility proteins and potential drug targets.
- Genetic evidence prioritizes circulating proteins for heart failure beyond shared BMI-related genetic liability.
- Development of a novel risk prediction model for rheumatoid arthritis-associated interstitial lung disease using plasma protein biomarkers and machine learning.
How sources frame it
- Xu Et Al.: neutral
- Su And Lu: neutral
- Lv Et Al.: neutral
These studies highlight the power of integrating proteomic and genomic data with advanced statistical methods to identify causal proteins and develop predictive models, offering promising avenues for therapeutic...
All evidence
All evidence
Development of a Novel Risk Prediction Model for Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): A Longitudinal Study
medRxiv (all subjects) · medrxiv.org · 2026-06-22 22:18 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 1Origin domains: 1Duplicates: -
Showing 1 / 0
Top publishers (this list)
- medRxiv (all subjects) (1)
Top origin domains (this list)
- medrxiv.org (1)